ALAVERT ALLERGY

Product NDC
0573-2621
11-digit product format
005732621
Labeler code
0573
Product ID
0573-2621_1ad9e626-55ca-4d43-b5ec-cc4d5bf19b07
Type
HUMAN OTC DRUG
Nonproprietary name
loratadine
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Labeler
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Application
NDA021375
Marketing category
NDA
Marketing start
2002-12-19
Marketing end
0000-00-00
Substance
LORATADINE
Active strength
10 mg/1
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0573-2621-19EA - Each0573-26211fcf8024-13e4-4f89-8a06-70c42d58133812014-01-04
0573-2621-65EA - Each0573-262188b60682-6817-47c6-87b5-205696e5dc0312012-07-24

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0573-2621-130057326211312 BLISTER PACK in 1 CARTON (0573-2621-13) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK12 blister pack2016-12-190000-00-00NoNoCurrent
0573-2621-190057326211918 BLISTER PACK in 1 CARTON (0573-2621-19) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK18 blister pack2002-12-190000-00-00NoNoCurrent
0573-2621-650057326216560 BLISTER PACK in 1 CARTON (0573-2621-65) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK60 blister pack2002-12-190000-00-00NoNoCurrent